Concepedia

Maximilian Stahl

MS

34

Publications

1.6K

Citations

21

H-Index

1999

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Yale University

Cornell University

Harvard University

Maximilian Stahl is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

1999–2024

34

Publications

34

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Maximilian Stahl, Kamal Menghrajani, Andriy Derkach et al. · Blood Advances · 2021 · 181 citations · Full text

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Maximilian Stahl, Michelle DeVeaux, Pau Montesinos et al. · Blood Advances · 2018 · 148 citations · Full text

, , +11

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Maximilian Stahl, Michelle DeVeaux, Théo de Witte et al. · Blood Advances · 2018 · 129 citations · Full text

, , +20

Plasmacytoid dendritic cell expansion defines a distinct subset of <i>RUNX1</i> -mutated acute myeloid leukemia

Wenbin Xiao, Alexander Chan, Michael R. Waarts et al. · Blood · 2020 · 111 citations · Full text

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

Kathleen C. Suozzi, Maximilian Stahl, Christine J. Ko et al. · JAAD Case Reports · 2016 · 100 citations · Full text

Rows per page

1–5 of 34